Assertio

ASRT

Market cap $78.9M

Overview Fund Trends Analyst Outlook Journalist POV

0.8201 USD

+0.0001

0.01%

At close Updated Oct 24, 4:00 PM EDT

Pre-market

After hours

0.8100

--0.0101

1.23%

1 day

0.01%

5 days

1.88%

1 month

-14.03%

3 months

9.42%

6 months

30.2%

Year to date

-3.53%

1 year

-17.37%

5 years

-69.85%

10 years

-98.81%

About: Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

Employees: 30

Healthcare Drug Manufacturers - Specialty & Generic